Chongqing Jiheng Pharmaceutical Co., Ltd. (SHE:002742)
China · Delayed Price · Currency is CNY 3.590
+0.090 (2.57%)
Aug 3, 2026, 3:04 PM CST
SHE:002742 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 806.81 | 899.85 | 1,196 | 2,030 | 2,077 | 2,489 |
Revenue Growth | -25.47% | -24.74% | -41.10% | -2.25% | -16.56% | -2.37% |
Gross Profit Gross Profit Growth | 113.31 | 129.95 | 196.78 | 380.04 | 307.68 | 405.41 |
Operating Income Operating Income Growth | -81.98 | -105.3 | -130.69 | 30.72 | -1.81 | -45.39 |
Net Income Net Income Growth | -345.38 | -419.68 | -650.13 | -452.05 | -317.88 | -333.44 |
Earnings Per Share EPS Growth | -0.46 | -0.61 | -0.95 | -1.05 | -0.74 | -0.77 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Building Materials Chemical Industry Building Materials Chemical Industry Growth | 349.94 | 544.05 | 1,037 | 1,139 | 1,583 |
Medicine Medicine Growth | 529.82 | 625.26 | 966.48 | 915.56 | 867.15 |
Unallocated Other Operations Unallocated Other Operations Growth | 20.09 | 26.41 | 26.96 | 22.16 | 38.69 |
Total Total Growth | 899.85 | 1,196 | 2,030 | 2,077 | 2,489 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 50.55 | 114.49 | 88.87 | 91.46 | 117.74 | 180.03 |
Total Debt Total Debt Growth | 529.96 | 526.1 | 1,750 | 1,774 | 1,672 | 1,565 |
Net Cash (Debt) Net Cash Growth | -479.42 | -411.61 | -1,662 | -1,682 | -1,554 | -1,385 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.64 | -0.60 | -2.43 | -3.91 | -3.62 | -3.21 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -101.92 | -25.87 | -47.02 | -51.59 | 49.12 | 139.84 |
Capital Expenditures CapEx Growth | -4.12 | -9.42 | -58.41 | -46.47 | -44.24 | -98.8 |
Free Cash Flow Free Cash Flow Growth | -106.03 | -35.29 | -105.43 | -98.07 | 4.87 | 41.03 |
Free Cash Flow Growth | - | - | - | - | -88.12% | -11.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 14.04% | 14.44% | 16.46% | 18.72% | 14.81% | 16.29% |
Operating Margin | -10.16% | -11.70% | -10.93% | 1.51% | -0.09% | -1.82% |
Pretax Margin | -44.99% | -48.53% | -52.60% | -16.15% | -11.57% | -13.76% |
Profit Margin | -42.81% | -46.64% | -54.37% | -22.27% | -15.30% | -13.40% |
FCF Margin | -13.14% | -3.92% | -8.82% | -4.83% | 0.24% | 1.65% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Forward PE | - | 16.30 | 16.30 | 16.30 | 16.30 | 16.30 |
P/FCF Ratio | - | - | - | - | 402.35 | 77.69 |
PS Ratio | 3.04 | 3.44 | 1.49 | 0.72 | 0.94 | 1.28 |